Drug Approval | November 01, 2021
Sun Pharma's Winlevi available in the US
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Acne affects up to 50 million Americans annually. The last FDA approval of an acne drug with a new MOA occurred nearly 40 years ago
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
Subscribe To Our Newsletter & Stay Updated
